Meeting
2015 Gastrointestinal Cancers Symposium
Real-world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in the United Kingdom (UK).
Authors
Astra M. Liepa
Eli Lilly and Company, Indianapolis, IN
Astra M. Liepa , Jacqueline Brown , Bela Bapat , James A. Kaye
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 184)
DOI
10.1200/jco.2015.33.3_suppl.184
Abstract #
184
Poster Bd #
D32
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Real world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in Mexico.
First Author: Kyla Jones
Poster
2018 Gastrointestinal Cancers Symposium
Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC).
First Author: Thomas Adam Abrams
Poster
2015 Gastrointestinal Cancers Symposium
Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.
First Author: Sebastian Ochenduszko
Poster
2013 Gastrointestinal Cancers Symposium
Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma.
First Author: Elizabeth Won